Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study

por Yamaguchi, Yoshiyuki, Katata, Yousuke, Sano, Fuminori, Tanioka, Hiroaki, Okawaki, Makoto, Yamamura, Masahiro, Nagasaka, Takeshi
Publicado 2020

Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study

por Yamaguchi, Yoshiyuki, Katata, Yousuke, Sano, Fuminori, Tanioka, Hiroaki, Okawaki, Makoto, Yamamura, Masahiro, Nagasaka, Takeshi
Publicado 2022

Neutrophil‑to‑lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer

por Tanioka, Hiroaki, Okawaki, Makoto, Yano, Shuya, Yoshimitsu, Tomomi, Tokuda, Kikue, Nyuya, Akihiro, Yamaguchi, Yoshiyuki, Nagasaka, Takeshi
Publicado 2023

Cetuximab retreatment in patients with metastatic colorectal cancer who exhibited a clinical benefit in response to prior cetuximab: A retrospective study

por Tanioka, Hiroaki, Asano, Motoi, Yoshida, Ryousuke, Waki, Naohisa, Uno, Futoshi, Ishizaki, Masahiro, Yamashita, Kazuki, Morishita, Yuki, Nagasaka, Takeshi
Publicado 2018

The possible involvement of intestine-derived IgA(1): a case of IgA nephropathy associated with Crohn’s disease

por Terasaka, Tomohiro, Uchida, Haruhito A., Umebayashi, Ryoko, Tsukamoto, Keiko, Tanaka, Keiko, Kitagawa, Masashi, Sugiyama, Hitoshi, Tanioka, Hiroaki, Wada, Jun
Publicado 2016

Upregulation of microRNA-31 is associated with poor prognosis in patients with advanced colorectal cancer

por Kubota, Nobuhito, Taniguchi, Fumitaka, Nyuya, Akihiro, Umeda, Yuzo, Mori, Yoshiko, Fujiwara, Toshiyoshi, Tanioka, Hiroaki, Tsuruta, Atsushi, Yamaguchi, Yoshiyuki, Nagasaka, Takeshi
Publicado 2020

Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin...

por Nagasaka, Takeshi, Mishima, Hideyuki, Sawaki, Akira, Shimokawa, Mototsugu, Inukai, Michio, Shinozaki, Katsunori, Tanioka, Hiroaki, Nasu, Junichiro, Nishina, Tomohiro, Hazama, Shoichi, Okajima, Masazumi, Yamaguchi, Yoshiyuki
Publicado 2016

Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colo...

por Tsuruta, Atsushi, Yamashita, Kazuki, Tanioka, Hiroaki, Tsuji, Akihito, Inukai, Michio, Yamakawa, Toshiki, Yamatsuji, Tomoki, Yoshimitsu, Masanori, Toyota, Kazuhiro, Yamano, Taketoshi, Nagasaka, Takeshi, Okajima, Masazumi
Publicado 2016

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer

por Taniguchi, Fumitaka, Nyuya, Akihiro, Toshima, Toshiaki, Yasui, Kazuya, Mori, Yoshiko, Okawaki, Makoto, Kishimoto, Hiroyuki, Umeda, Yuzo, Fujiwara, Toshiyoshi, Tanioka, Hiroaki, Yamaguchi, Yoshiyuki, Goel, Ajay, Nagasaka, Takeshi
Publicado 2021

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study prot...

por Tanioka, Hiroaki, Nagasaka, Takeshi, Uno, Futoshi, Inoue, Masafumi, Okita, Hiroyuki, Katata, Yosuke, Kanzaki, Hiromitsu, Kuramochi, Hidekazu, Satake, Hironaga, Shindo, Yoshiaki, Doi, Akira, Nasu, Jyunichiro, Yamashita, Haruhiro, Yamaguchi, Yoshiyuki
Publicado 2019

Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations

por Kawai, Takashi, Nyuya, Akihiro, Mori, Yoshiko, Tanaka, Takehiro, Tanioka, Hiroaki, Yasui, Kazuya, Toshima, Toshiaki, Taniguchi, Fumitaka, Shigeyasu, Kunitoshi, Umeda, Yuzo, Fujiwara, Toshiyoshi, Okawaki, Makoto, Yamaguchi, Yoshiyuki, Goel, Ajay, Nagasaka, Takeshi
Publicado 2021

Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104)

por Satake, Hironaga, Iwatsuki, Masaaki, Uenosono, Yoshikazu, Shiraishi, Takeshi, Tanioka, Hiroaki, Saeki, Hiroshi, Sugimachi, Keishi, Kitagawa, Dai, Shimokawa, Mototsugu, Oki, Eiji, Emi, Yasunori, Kakeji, Yoshihiro, Tsuji, Akihito, Akagi, Yoshito, Natsugoe, Shoji, Baba, Hideo, Maehara, Yoshihiko
Publicado 2016

Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases

por Satake, Hironaga, Hashida, Hiroki, Tanioka, Hiroaki, Miyake, Yasuhiro, Yoshioka, Shinichi, Watanabe, Takanori, Matsuura, Masato, Kyogoku, Takahisa, Inukai, Michio, Kotake, Takeshi, Okita, Yoshihiro, Matsumoto, Toshihiko, Yasui, Hisateru, Kotaka, Masahito, Kato, Takeshi, Kaihara, Satoshi, Tsuji, Akihito
Publicado 2021

Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)

por Suzuki, Nobuaki, Hazama, Shoichi, Nagasaka, Takeshi, Tanioka, Hiroaki, Iwamoto, Yasuo, Negoro, Yuji, Yamauchi, Masami, Kobayashi, Michiya, Okuda, Hiroshi, Fujishima, Noriaki, Nishimura, Taku, Yamanaka, Naoki, Toyota, Kazuhiro, Mori, Yoshiko, Nakagami, Yuki, Shimokawa, Mototsugu, Nagano, Hiroaki, Okajima, Masazumi
Publicado 2019

A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unrese...

por Iwamoto, Shigeyoshi, Ooki, Akira, Morita, Satoshi, Hara, Hiroki, Tanioka, Hiroaki, Satake, Hironaga, Kataoka, Masato, Kotaka, Masahito, Kagawa, Yoshinori, Nakamura, Masato, Shingai, Tatsushi, Ishikawa, Masashi, Miyake, Yasuhiro, Sudo, Takeshi, Hashiguchi, Yojiro, Yabuno, Taichi, Sakamoto, Junichi, Tsuji, Akihito, Ando, Masahiko, Yamaguchi, Kensei
Publicado 2018

Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II Q...

por Ooki, Akira, Morita, Satoshi, Iwamoto, Shigeyoshi, Hara, Hiroki, Tanioka, Hiroaki, Satake, Hironaga, Kataoka, Masato, Kotaka, Masahito, Kagawa, Yoshinori, Nakamura, Masato, Shingai, Tatsushi, Ishikawa, Masashi, Miyake, Yasuhiro, Suto, Takeshi, Hashiguchi, Yojiro, Yabuno, Taichi, Sakamoto, Junichi, Tsuji, Akihito, Ando, Masahiko, Yamaguchi, Kensei
Publicado 2020

Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for un...

por Ooki, Akira, Morita, Satoshi, Tsuji, Akihito, Iwamoto, Shigeyoshi, Hara, Hiroki, Tanioka, Hiroaki, Satake, Hironaga, Kataoka, Masato, Kotaka, Masahito, Kagawa, Yoshinori, Nakamura, Masato, Shingai, Tatsushi, Ishikawa, Masashi, Miyake, Yasuhiro, Suto, Takeshi, Hashiguchi, Yojiro, Yabuno, Taichi, Ando, Masahiko, Sakamoto, Junichi, Yamaguchi, Kensei
Publicado 2020

A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)

por Shinozaki, Katsunori, Yamada, Takeshi, Nasu, Junichiro, Matsumoto, Toshihiko, Yuasa, Yasuhiro, Shiraishi, Takeshi, Nagano, Hiroaki, Moriyama, Ichiro, Fujiwara, Toshiyoshi, Miguchi, Masashi, Yoshida, Ryosuke, Nozaka, Kimiyasu, Tanioka, Hiroaki, Nagasaka, Takeshi, Kurisu, Yasuro, Kobayashi, Michiya, Tsuchihashi, Kenji, Inukai, Michio, Kikuchi, Takashi, Nishina, Tomohiro
Publicado 2020

Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase...

por Kato, Takeshi, Kagawa, Yoshinori, Kuboki, Yasutoshi, Gamoh, Makio, Komatsu, Yoshito, Yasui, Hirofumi, Satake, Hironaga, Oki, Eiji, Tanioka, Hiroaki, Kotaka, Masahito, Makiyama, Akitaka, Denda, Tadamichi, Goto, Masahiro, Yoshino, Takayuki, Yamazaki, Kentaro, Soeda, Junpei, Shibuya, Kazunori, Iwata, Masaru, Oba, Koji, Yamaguchi, Kensei
Publicado 2021

Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase I...

por Ooki, Akira, Morita, Satoshi, Tsuji, Akihito, Iwamoto, Shigeyoshi, Hara, Hiroki, Tanioka, Hiroaki, Satake, Hironaga, Kataoka, Masato, Kotaka, Masahito, Kagawa, Yoshinori, Nakamura, Masato, Shingai, Tatsushi, Ishikawa, Masashi, Miyake, Yasuhiro, Suto, Takeshi, Hashiguchi, Yojiro, Yabuno, Taichi, Ando, Masahiko, Sakamoto, Junichi, Yamaguchi, Kensei
Publicado 2022